AngioScore Obtains Japanese Approval for AngioSculpt Scoring Balloon Catheter.FREMONT, Calif. -- AngioScore, Inc., a developer of novel angioplasty catheters for use in the treatment of cardiovascular disease Cardiovascular disease Disease that affects the heart and blood vessels. Mentioned in: Lipoproteins Test cardiovascular disease , announced today that its flagship product A primary product of a company, which is typically why the company was founded and/or what made it well known. For example, MS-DOS, Windows and the Microsoft Office suite have been flagship products of Microsoft. CorelDRAW is a flagship product of Corel Corporation. , the AngioSculpt[R] Scoring Balloon Catheter balloon catheter n. A catheter with an inflatable balloon at its tip, used especially to expand a partially obstructed blood vessel or bodily passage and to measure blood pressure in a blood vessel. Also called balloon-tip catheter. , has received import approval from Japan's Ministry of Health, Labor and Welfare (MHLW/PMDA) for the interventional treatment of coronary artery disease coronary artery disease, condition that results when the coronary arteries are narrowed or occluded, most commonly by atherosclerotic deposits of fibrous and fatty tissue. in that country. AngioScore and USCI USCI United States Colored Infantry USCI University College Sedaya International USCI United States Computers, Incorporated Japan, a prominent distributor of medical devices in Japan, have collaborated for several years to achieve this critically important milestone. Japan represents a major market opportunity for AngioScore, second only to the United States United States, officially United States of America, republic (2005 est. pop. 295,734,000), 3,539,227 sq mi (9,166,598 sq km), North America. The United States is the world's third largest country in population and the fourth largest country in area. in the number of cardiovascular procedures performed on an annual basis. "We are extremely pleased to have accomplished this critically important milestone," said Thomas R. Trotter, president and CEO (1) (Chief Executive Officer) The highest individual in command of an organization. Typically the president of the company, the CEO reports to the Chairman of the Board. of AngioScore. "Very few small medical device companies ever gain access to the Japanese market, given that nation's high performance standards and stringent quality control requirements. Today's announcement is the result of a multi-year joint effort with our marketing partner, USCI Japan, and is a testament to the hard work and dedication of many people in both organizations." Michael Van Zandt Van Zandt, a surname, may refer to: People
Added Trotter: "With more than 180,000 interventional procedures being done in Japan annually, we believe that the AngioSculpt will quickly gain a significant market presence. More than 10,000 AngioSculpt catheters have been used worldwide and have an outstanding performance record in the treatment of both coronary and peripheral artery disease." The AngioSculpt Scoring Balloon Catheter represents the next generation in angioplasty catheters. Its innovative nitinol element provides unique anti-slipping properties while circumferentially dilating plaque, providing a precise and predictable dilatation dilatation /dil·a·ta·tion/ (dil?ah-ta´shun) 1. the condition, as of an orifice or tubular structure, of being dilated or stretched beyond normal dimensions. 2. the act of dilating or stretching. across a wide range of lesion types. The AngioSculpt provides the versatility and effectiveness of a new technology together with the simplicity and deliverability of a high-performance balloon catheter. About USCI Japan USCI Japan, Ltd (www.usci.co.jp) is a USCI Holdings (www.usciholdings.com) member company with headquarters in Tokyo, Japan. MC (www.welcome-mc.co.jp) and MedCare (http://www.medocare.net) are also USCI Holdings member companies. USCI Japan can be contacted at +81-3-3578-7780. About AngioScore AngioScore, Inc (www.angioscore.com) is a privately funded endovascular company located in Fremont, California For the unincorporated community in Yolo County, California, see . Fremont (IPA: /ˈfriːmɒnt/) is a city in California that was incorporated on January 23, 1956, from the merger of five smaller communities: . The company's first product is the AngioSculpt Scoring Balloon Catheter. AngioScore can be contacted at (510) 933-7900 or info@angioscore.com Note: This press release contains forward-looking statements that are based upon management's current expectations and are inherently uncertain. Actual results and timing of events could differ materially from current expectations and forward-looking statements. |
|
||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion